The latest financial forecast disclosed by bio-based materials company Origin Materials Inc. (ORGN) indicates that, with its current cash and cash equivalents, the company is expected to continue executing its established operational plan until the third quarter of 2026.

This calculation result highlights the company's robust cash flow management capability, providing financial security for medium- and long-term technology research and development as well as capacity expansion. Against the backdrop of rapid development in the biomaterials industry driven by carbon neutrality goals, this capital reserve will support the company in advancing the commercialization of plant-based chemicals. The company stated it will continue to optimize its capital structure and enhance capital efficiency through strategic cooperation and technological innovation.